EMA launches Website for accelerating EU Clinical Trials
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The EMA has launched a dedicated website for the Accelerating clinical trials in the European Union (ACT EU) initiative, co-led by the European Commission, the Heads of Medicines Agencies and the European Medicines Agency (EMA). The website contains updates on the progress of ACT EU priority actions, which aim to improve the clinical trials environment in the EU through harmonization, innovation, and stakeholder collaboration.
Key resources include latest information on:
- the Multi-stakeholder platform;
- the implementation of the Clinical Trials Regulation (CTR);
- voluntary procedures in scientific advice;
- the Simultaneous national scientific advice (SNSA) pilot.
In addition, the EMA held a workshop on establishing a multi-stakeholder platform on 22/23 June 2023. Following the workshop, the presentations shown and also the video recordings were published on the EMA website about the workshop.
Related GMP News
16.04.2026EMA Guidance on Conducting Clinical Trials during Public Health Emergencies
16.04.2026EMA accelerates Development of Medicines
16.04.2026What are the GMP Requirements for Drug Development?
26.03.2026FDA Guidance on Statistical Methods for Clinical Trials
26.03.2026Final ICH M11 CeSHarP Guideline
24.02.2026Good AI Practice in Drug Development